Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name S1 BIOPHARMA, INC. Proposed Ticker SXBUU CUSIP 835428103 Business Description A clinical-stage biopharmaceutical company focused on the development and commercialization of novel, first-in-class therapies for sexual dysfunction. Lead Underwriter MLV & Co. LLC Co-Managers Northland Securities, Inc Initial Shares 27,50,000 Revised Initial Shares 17,50,000 Initial Price $12.00-$14.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.